Risk-adaptive optimization: Selective boosting of high-risk tumor subvolumes

International Journal of Radiation Oncology Biology Physics

Volumn 66, Issue 5, 2006, Pages 1528-1542

  Kim, Yusung ^a   Tomé, Wolfgang A ^a  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

Biologic optimization; IMRT; Inverse planning; NTCP; TCP

Indexed keywords

OPTIMIZATION; PROBABILITY; RISK ASSESSMENT; TISSUE;

BIOLOGIC OPTIMIZATION; IMRT; INVERSE PLANNING; NTCP; RISK CLASSIFICATION; TUMOR CONTROL PROBABILITY (TCP);

TUMORS;

ARTICLE; CANCER CONTROL; CANCER MODEL; CANCER RISK; CORRELATION ANALYSIS; GEOMETRY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROSTATE CANCER; RADIATION DOSE; RADIATION DOSE DISTRIBUTION; RISK ASSESSMENT; TUMOR VOLUME;

DOSE-RESPONSE RELATIONSHIP, RADIATION; FEASIBILITY STUDIES; HUMANS; MALE; MODELS, BIOLOGICAL; NEOPLASM RECURRENCE, LOCAL; PROSTATIC NEOPLASMS; RADIATION INJURIES; RADIATION TOLERANCE; RADIOTHERAPY DOSAGE; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; RADIOTHERAPY, INTENSITY-MODULATED; RECTUM; RELATIVE BIOLOGICAL EFFECTIVENESS; RISK; TECHNOLOGY, RADIOLOGIC; URINARY BLADDER;

EID: 33751194101     PISSN: 03603016     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2006.08.032     Document Type: Article

References (27)

1. Webb S., and Nahum A.E. A model for calculating tumor control probability in radiotherapy including the effects of inhomogeneous distributions of dose and clonogenic cell density. Phys Med Biol 38 (1993) 653-666
2. Bentzen S.M. Theragnostic imaging for radiation oncology: Dose-painting by numbers. Lancet Oncol 6 (2005) 112-117
3. Chao K.S.C., Bosch W.R., Mutic S., et al. A novel approach to overcome hypoxic tumour resistance: Cu-ATSM-guided intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 49 (2001) 1171-1182
4. Chapman J.D., Bradley J.D., and Eary J.F. Molecular (Functional) imaging for radiotherapy applications: An RTOG symposium. Int J Radiat Oncol Biol Phys 55 (2003) 294-301
5. Thorwarth D., Eschmann S.M., Scheiderbauer J., Paulsen F., and Alber M. Kinetic analysis of dynamic 18F-fluoromisonidazole PET correlates with radiation treatment outcome in head-and-neck cancer. BMC Cancer 5 (2005) 152
6. Tomé W.A., Jaradat H.A., McNutt T.R., et al. Application of multimodality imaging to radiation therapy treatment of brain tumors. Int J Radiat Oncol Biol Phys 54 Suppl. 1 (2002) 240-241
7. Tomé W.A., and Fowler J.F. Selective boosting of tumor subvolumes. Int J Radiat Oncol Biol Phys 48 (2000) 593-599
8. Goitein M., Niemierko A., and Okunieff P. The probability of controlling an inhomogeneously irradiated tumor. In: Kaulner K., Carey B., and Crellin A. (Eds). Quantitative imaging in oncology (1995), British Institute of Radiology, London 25-32 Proceedings of the 19th LH Gray Conference
9. Deasy J. Tumor control probability models for nonuniform dose distributions. In: Paliwal B.R., Fowler J.F., Herbert D.E., et al. (Eds). Volume and kinetics in tumor control & normal tissue complication (1997), Medical Physics Publishing, Madison, WI 65-85
10. Popple R.A., Ove R., and Shen S. Tumor control probability for selective boosting of hypoxic subvolumes, including the effect of reoxygenation. Int J Radiat Oncol Biol Phys 54 (2002) 921-927
11. Thames H.D., Schultheiss T.E., Hendry J.H., et al. Can modest escalations of dose be detected as increased tumor control?. Int J Radiat Oncol Biol Phys 22 (1992) 241-246
12. Bartelink H., Horiot J.C., Poortmans P., et al. Recurrence rates after treatment of breast cancer with standard radiotherapy with or without additional radiation. N Eng J Med S345 (2001) 1378-1387
13. Brahme A. Treatment optimization using physical and radiobiological objective functions. In: Smith A.R. (Ed). Radiation therapy physics (1995), Springer, Berlin 209-216
14. Ågren A.K., Brahme A., and Turesson I. Optimization of uncomplicated control for head and neck tumors. Int J Radiat Oncol Biol Phys 19 (1990) 1077-1085
15. Munro T.R., and Gilbert C.W. The relation between tumor lethal doses and the radiosensitivity of tumor cells. Br J Radiol 34 (1961) 246-251
16. Fowler J. Normal tissue complication probabilities: How well do the models work?. Phys Med XVII (2001) 24-34
17. Källman P., Ågren A., and Brahme A. Tumor and normal tissue responses to fractionated non-uniform dose delivery. Int J Radiat Oncol Biol Phys 62 (1992) 249-262
18. Rancati T., Fiorino C., Gagliardi G., et al. Fitting late rectal bleeding data using different NTCP models: Results from an Italian multi-centric study (AIROPROS0101). Radiother Oncol 73 (2004) 21-32
19. Emami B., Lyman J., Brown A., et al. Tolerance of normal tissue to therapeutic irradiation. Int J Radiat Oncol Biol Phys 21 (1991) 109-122
20. Boersma L.J., van den Brink M., Bruce A.M., et al. Estimation of the incidence of late bladder and rectum complications after high-dose (70-80 Gy) conformal radiotherapy for prostate cancer, using dose-volume histograms. Int J Radiat Oncol Biol Phys 41 (1998) 83-92
21. Eisbruch A., Ten Haken R.K., Kim H.M., et al. Dose, volume, and function relationships in parotid salivary glands following conformal and intensity-modulated irradiation of head and neck cancer. Int J Radiat Oncol Biol Phys 45 (1999) 577-587
22. Dawson L.A., Normolle D., Balter J.M., et al. Analysis of radiation-induced liver disease using the Lyman NTCP model. Int J Radiat Oncol Biol Phys 53 (2002) 810-821
23. Levegrün S., Jackson A., Zelefsky M.J., et al. Risk group dependence of dose response for biopsy outcome after three-dimensional conformal radiation therapy of prostate cancer. Radiother Oncol 63 (2002) 11-26
24. Mohan R., Wang X., Jackson A., et al. The potential and limitations of the inverse radiotherapy technique. Radiother Oncol 32 (1994) 232-248
25. Brahme A. Optimized radiation therapy based on radiobiological objectives. Semin Radiat Oncol 9 (1999) 35-47
26. Suit H., Skates S., Taghian A., et al. Clinical implications of heterogeneity of tumor response to radiation therapy. Radiother Oncol 25 (1992) 251-260
27. Tomé W.A., and Fowler J.F. On cold spots in tumor subvolumes. Med Phys 29 (2002) 1590-1598